 |
Company News
Company News
-
02/07/2018
Cardinal Health (NYSE:CAH) today announced that its board of directors approved a regular quarterly dividend of $0.4624 per share, payable April 15, 2018 to shareholders of record on April 2,...
-
02/01/2018
Cardinal Health (NYSE: CAH) today announced the closing of its divestiture of its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma"). The sale...
-
01/12/2018
Cardinal Health (NYSE: CAH) plans to release second-quarter financial results for its fiscal year 2018 on February 8 prior to the opening of trading on the New York Stock Exchange. The company...
01/11/2018Deliverability of EluNIR™ stent in complex patient anatomy demonstrated during first commercial cases at Columbia University Medical Center and Piedmont Heart InstituteDUBLIN, Ohio, January 11, 2018 — Cordis, a Cardinal Health company, and Medinol today announced that the first commercial cases using the EluNIR™ drug-eluting stent (DES) in the United States...
-
01/04/2018
Cardinal Health announced today that Mike Kaufmann, chief executive officer, will present at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Jan. 8, 2018, at 11 a.m....
12/07/2017Growing interest in biosimilars, caution about CAR T, and increased use of genetic testing for AML patients are among the key findings.Cardinal Health Specialty Solutions today introduced the second edition of Oncology Insights, a research-based report outlining the views of more than 200 U.S. oncologists on the latest medical...
11/30/2017EluNIR is shown to effectively treat highly complex disease with optimized stent and delivery systemCordis, a Cardinal Health company, and Medinol today announced United States Food and Drug Administration (FDA) approval of the EluNIR™ drug-eluting stent (DES) for the treatment of patients...
-
11/16/2017Company to Collaborate with Key Partners across Ohio, Kentucky, Tennessee and West Virginia
Cardinal Health (NYSE: CAH) today launched its new Opioid Action Program, aimed at helping communities in four of the nation's hardest-hit states across Appalachia combat the opioid epidemic. The...
-
11/14/2017
Cardinal Health (NYSE: CAH) today announced that it has signed a definitive agreement to sell its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co., Ltd. ("Shanghai Pharma")...
11/14/2017Cardinal Health earns 100 percent on Human Rights Campaign Foundation's annual scorecard for tenth consecutive yearAs an organization that believes cultivating a diverse and inclusive work environment is crucial to corporate success, Cardinal Health earned a perfect score on the 2018 Corporate Equality Index...
